世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本のカルボプラチンAPI市場の洞察、2027年までの予測


Global and Japan Carboplatin API Market Insights, Forecast to 2027

抗腫瘍性のAPIで、外観は透明な結晶性の粉末、分子式はC6H12N2O4Pt、CAS番号は41575-94-4です。 市場分析と洞察。世界と日本のカルボプラチンAPI市場 本レポートは、世界と日本のカルボプラチンAPI市場に焦点... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月19日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

抗腫瘍性のAPIで、外観は透明な結晶性の粉末、分子式はC6H12N2O4Pt、CAS番号は41575-94-4です。

市場分析と洞察。世界と日本のカルボプラチンAPI市場
本レポートは、世界と日本のカルボプラチンAPI市場に焦点を当てています。
2020年のカルボプラチンAPIの世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで2027年末にはXX百万米ドルに達すると予想されています。日本では、カルボプラチンAPIの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

世界のカルボプラチンAPIの範囲と市場規模
カルボプラチンAPI市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のCarboplatin API市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場では、2016-2027年のカルボプラチンAPIの市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
純度98%以上
純度99%以上

用途別セグメント
カルボプラチン注射剤
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
ユミコア
Tapi Teva
Vinkem Labs
シプラ
ケム・ジェニックス
フレゼニウス・カビ・オンコロジー
ヘレウス
ジョーソン・マッセイ
Qilu Pharmaceutial
杭州龍神生物技術有限公司
エースブライト
昆明桂安製薬


ページTOPに戻る


目次

1 Study Coverage
1.1 Carboplatin API Product Introduction
1.2 Market by Type
1.2.1 Global Carboplatin API Market Size Growth Rate by Type
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Market by Application
1.3.1 Global Carboplatin API Market Size Growth Rate by Application
1.3.2 Carboplatin Injection
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Carboplatin API Market Size, Estimates and Forecasts
2.1.1 Global Carboplatin API Revenue 2016-2027
2.1.2 Global Carboplatin API Sales 2016-2027
2.2 Global Carboplatin API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Carboplatin API Historical Market Size by Region (2016-2021)
2.3.1 Global Carboplatin API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Carboplatin API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Carboplatin API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Carboplatin API Sales Forecast by Region (2022-2027)
2.4.2 Global Carboplatin API Revenue Forecast by Region (2022-2027)

3 Global Carboplatin API Competitor Landscape by Players
3.1 Global Top Carboplatin API Manufacturers by Sales
3.1.1 Global Carboplatin API Sales by Manufacturer (2016-2021)
3.1.2 Global Carboplatin API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Carboplatin API Manufacturers by Revenue
3.2.1 Key Carboplatin API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Carboplatin API Revenue by Manufacturers (2016-2021)
3.2.3 Global Carboplatin API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Carboplatin API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Carboplatin API Revenue in 2020
3.2.6 Global Carboplatin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Carboplatin API Price by Manufacturers
3.4 Global Carboplatin API Manufacturing Base Distribution, Product Types
3.4.1 Carboplatin API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Carboplatin API Product Type
3.4.3 Date of International Manufacturers Enter into Carboplatin API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Carboplatin API Market Size by Type (2016-2021)
4.1.1 Global Carboplatin API Sales by Type (2016-2021)
4.1.2 Global Carboplatin API Revenue by Type (2016-2021)
4.1.3 Carboplatin API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Carboplatin API Market Size Forecast by Type (2022-2027)
4.2.1 Global Carboplatin API Sales Forecast by Type (2022-2027)
4.2.2 Global Carboplatin API Revenue Forecast by Type (2022-2027)
4.2.3 Carboplatin API Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Carboplatin API Market Size by Application (2016-2021)
5.1.1 Global Carboplatin API Sales by Application (2016-2021)
5.1.2 Global Carboplatin API Revenue by Application (2016-2021)
5.1.3 Carboplatin API Price by Application (2016-2021)
5.2 Carboplatin API Market Size Forecast by Application (2022-2027)
5.2.1 Global Carboplatin API Sales Forecast by Application (2022-2027)
5.2.2 Global Carboplatin API Revenue Forecast by Application (2022-2027)
5.2.3 Global Carboplatin API Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Carboplatin API Market Size YoY Growth 2016-2027
6.1.1 Japan Carboplatin API Sales YoY Growth 2016-2027
6.1.2 Japan Carboplatin API Revenue YoY Growth 2016-2027
6.1.3 Japan Carboplatin API Market Share in Global Market 2016-2027
6.2 Japan Carboplatin API Market Size by Players (International and Local Players)
6.2.1 Japan Top Carboplatin API Players by Sales (2016-2021)
6.2.2 Japan Top Carboplatin API Players by Revenue (2016-2021)
6.3 Japan Carboplatin API Historic Market Review by Type (2016-2021)
6.3.1 Japan Carboplatin API Sales Market Share by Type (2016-2021)
6.3.2 Japan Carboplatin API Revenue Market Share by Type (2016-2021)
6.3.3 Japan Carboplatin API Price by Type (2016-2021)
6.4 Japan Carboplatin API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Carboplatin API Sales Forecast by Type (2022-2027)
6.4.2 Japan Carboplatin API Revenue Forecast by Type (2022-2027)
6.4.3 Japan Carboplatin API Price Forecast by Type (2022-2027)
6.5 Japan Carboplatin API Historic Market Review by Application (2016-2021)
6.5.1 Japan Carboplatin API Sales Market Share by Application (2016-2021)
6.5.2 Japan Carboplatin API Revenue Market Share by Application (2016-2021)
6.5.3 Japan Carboplatin API Price by Application (2016-2021)
6.6 Japan Carboplatin API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Carboplatin API Sales Forecast by Application (2022-2027)
6.6.2 Japan Carboplatin API Revenue Forecast by Application (2022-2027)
6.6.3 Japan Carboplatin API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Carboplatin API Market Size YoY Growth 2016-2027
7.2 North America Carboplatin API Market Facts & Figures by Country
7.2.1 North America Carboplatin API Sales by Country (2016-2021)
7.2.2 North America Carboplatin API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Carboplatin API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Carboplatin API Market Facts & Figures by Region
8.2.1 Asia Pacific Carboplatin API Sales by Region (2016-2021)
8.2.2 Asia Pacific Carboplatin API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Carboplatin API Market Size YoY Growth 2016-2027
9.2 Europe Carboplatin API Market Facts & Figures by Country
9.2.1 Europe Carboplatin API Sales by Country (2016-2021)
9.2.2 Europe Carboplatin API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Carboplatin API Market Size YoY Growth 2016-2027
10.2 Latin America Carboplatin API Market Facts & Figures by Country
10.2.1 Latin America Carboplatin API Sales by Country (2016-2021)
10.2.2 Latin America Carboplatin API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Carboplatin API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Carboplatin API Market Facts & Figures by Country
11.2.1 Middle East and Africa Carboplatin API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Carboplatin API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Umicore
12.1.1 Umicore Corporation Information
12.1.2 Umicore Description and Business Overview
12.1.3 Umicore Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Umicore Carboplatin API Products Offered
12.1.5 Umicore Recent Development
12.2 Tapi Teva
12.2.1 Tapi Teva Corporation Information
12.2.2 Tapi Teva Description and Business Overview
12.2.3 Tapi Teva Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Tapi Teva Carboplatin API Products Offered
12.2.5 Tapi Teva Recent Development
12.3 Vinkem Labs
12.3.1 Vinkem Labs Corporation Information
12.3.2 Vinkem Labs Description and Business Overview
12.3.3 Vinkem Labs Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Vinkem Labs Carboplatin API Products Offered
12.3.5 Vinkem Labs Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Description and Business Overview
12.4.3 Cipla Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cipla Carboplatin API Products Offered
12.4.5 Cipla Recent Development
12.5 Chem Genix
12.5.1 Chem Genix Corporation Information
12.5.2 Chem Genix Description and Business Overview
12.5.3 Chem Genix Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chem Genix Carboplatin API Products Offered
12.5.5 Chem Genix Recent Development
12.6 Fresenius Kabi Oncology
12.6.1 Fresenius Kabi Oncology Corporation Information
12.6.2 Fresenius Kabi Oncology Description and Business Overview
12.6.3 Fresenius Kabi Oncology Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Oncology Carboplatin API Products Offered
12.6.5 Fresenius Kabi Oncology Recent Development
12.7 Heraeus
12.7.1 Heraeus Corporation Information
12.7.2 Heraeus Description and Business Overview
12.7.3 Heraeus Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Heraeus Carboplatin API Products Offered
12.7.5 Heraeus Recent Development
12.8 Johson Matthey
12.8.1 Johson Matthey Corporation Information
12.8.2 Johson Matthey Description and Business Overview
12.8.3 Johson Matthey Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johson Matthey Carboplatin API Products Offered
12.8.5 Johson Matthey Recent Development
12.9 Qilu Pharmaceutial
12.9.1 Qilu Pharmaceutial Corporation Information
12.9.2 Qilu Pharmaceutial Description and Business Overview
12.9.3 Qilu Pharmaceutial Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Qilu Pharmaceutial Carboplatin API Products Offered
12.9.5 Qilu Pharmaceutial Recent Development
12.10 Hangzhou Longshine Bio-Tech
12.10.1 Hangzhou Longshine Bio-Tech Corporation Information
12.10.2 Hangzhou Longshine Bio-Tech Description and Business Overview
12.10.3 Hangzhou Longshine Bio-Tech Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hangzhou Longshine Bio-Tech Carboplatin API Products Offered
12.10.5 Hangzhou Longshine Bio-Tech Recent Development
12.11 Umicore
12.11.1 Umicore Corporation Information
12.11.2 Umicore Description and Business Overview
12.11.3 Umicore Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Umicore Carboplatin API Products Offered
12.11.5 Umicore Recent Development
12.12 Kunming Guiyan Pharmaceutical
12.12.1 Kunming Guiyan Pharmaceutical Corporation Information
12.12.2 Kunming Guiyan Pharmaceutical Description and Business Overview
12.12.3 Kunming Guiyan Pharmaceutical Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kunming Guiyan Pharmaceutical Products Offered
12.12.5 Kunming Guiyan Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Carboplatin API Industry Trends
13.2 Carboplatin API Market Drivers
13.3 Carboplatin API Market Challenges
13.4 Carboplatin API Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Carboplatin API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

It is an anti-tumor API with the appearance of transparent crystalline powder, the molecular formula is C6H12N2O4Pt, and CAS number is 41575-94-4.

Market Analysis and Insights: Global and Japan Carboplatin API Market
This report focuses on global and Japan Carboplatin API market.
In 2020, the global Carboplatin API market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Carboplatin API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Carboplatin API Scope and Market Size
Carboplatin API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Carboplatin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Carboplatin API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Carboplatin Injection
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Umicore
Tapi Teva
Vinkem Labs
Cipla
Chem Genix
Fresenius Kabi Oncology
Heraeus
Johson Matthey
Qilu Pharmaceutial
Hangzhou Longshine Bio-Tech
Acebright
Kunming Guiyan Pharmaceutical



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Carboplatin API Product Introduction
1.2 Market by Type
1.2.1 Global Carboplatin API Market Size Growth Rate by Type
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Market by Application
1.3.1 Global Carboplatin API Market Size Growth Rate by Application
1.3.2 Carboplatin Injection
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Carboplatin API Market Size, Estimates and Forecasts
2.1.1 Global Carboplatin API Revenue 2016-2027
2.1.2 Global Carboplatin API Sales 2016-2027
2.2 Global Carboplatin API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Carboplatin API Historical Market Size by Region (2016-2021)
2.3.1 Global Carboplatin API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Carboplatin API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Carboplatin API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Carboplatin API Sales Forecast by Region (2022-2027)
2.4.2 Global Carboplatin API Revenue Forecast by Region (2022-2027)

3 Global Carboplatin API Competitor Landscape by Players
3.1 Global Top Carboplatin API Manufacturers by Sales
3.1.1 Global Carboplatin API Sales by Manufacturer (2016-2021)
3.1.2 Global Carboplatin API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Carboplatin API Manufacturers by Revenue
3.2.1 Key Carboplatin API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Carboplatin API Revenue by Manufacturers (2016-2021)
3.2.3 Global Carboplatin API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Carboplatin API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Carboplatin API Revenue in 2020
3.2.6 Global Carboplatin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Carboplatin API Price by Manufacturers
3.4 Global Carboplatin API Manufacturing Base Distribution, Product Types
3.4.1 Carboplatin API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Carboplatin API Product Type
3.4.3 Date of International Manufacturers Enter into Carboplatin API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Carboplatin API Market Size by Type (2016-2021)
4.1.1 Global Carboplatin API Sales by Type (2016-2021)
4.1.2 Global Carboplatin API Revenue by Type (2016-2021)
4.1.3 Carboplatin API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Carboplatin API Market Size Forecast by Type (2022-2027)
4.2.1 Global Carboplatin API Sales Forecast by Type (2022-2027)
4.2.2 Global Carboplatin API Revenue Forecast by Type (2022-2027)
4.2.3 Carboplatin API Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Carboplatin API Market Size by Application (2016-2021)
5.1.1 Global Carboplatin API Sales by Application (2016-2021)
5.1.2 Global Carboplatin API Revenue by Application (2016-2021)
5.1.3 Carboplatin API Price by Application (2016-2021)
5.2 Carboplatin API Market Size Forecast by Application (2022-2027)
5.2.1 Global Carboplatin API Sales Forecast by Application (2022-2027)
5.2.2 Global Carboplatin API Revenue Forecast by Application (2022-2027)
5.2.3 Global Carboplatin API Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Carboplatin API Market Size YoY Growth 2016-2027
6.1.1 Japan Carboplatin API Sales YoY Growth 2016-2027
6.1.2 Japan Carboplatin API Revenue YoY Growth 2016-2027
6.1.3 Japan Carboplatin API Market Share in Global Market 2016-2027
6.2 Japan Carboplatin API Market Size by Players (International and Local Players)
6.2.1 Japan Top Carboplatin API Players by Sales (2016-2021)
6.2.2 Japan Top Carboplatin API Players by Revenue (2016-2021)
6.3 Japan Carboplatin API Historic Market Review by Type (2016-2021)
6.3.1 Japan Carboplatin API Sales Market Share by Type (2016-2021)
6.3.2 Japan Carboplatin API Revenue Market Share by Type (2016-2021)
6.3.3 Japan Carboplatin API Price by Type (2016-2021)
6.4 Japan Carboplatin API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Carboplatin API Sales Forecast by Type (2022-2027)
6.4.2 Japan Carboplatin API Revenue Forecast by Type (2022-2027)
6.4.3 Japan Carboplatin API Price Forecast by Type (2022-2027)
6.5 Japan Carboplatin API Historic Market Review by Application (2016-2021)
6.5.1 Japan Carboplatin API Sales Market Share by Application (2016-2021)
6.5.2 Japan Carboplatin API Revenue Market Share by Application (2016-2021)
6.5.3 Japan Carboplatin API Price by Application (2016-2021)
6.6 Japan Carboplatin API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Carboplatin API Sales Forecast by Application (2022-2027)
6.6.2 Japan Carboplatin API Revenue Forecast by Application (2022-2027)
6.6.3 Japan Carboplatin API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Carboplatin API Market Size YoY Growth 2016-2027
7.2 North America Carboplatin API Market Facts & Figures by Country
7.2.1 North America Carboplatin API Sales by Country (2016-2021)
7.2.2 North America Carboplatin API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Carboplatin API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Carboplatin API Market Facts & Figures by Region
8.2.1 Asia Pacific Carboplatin API Sales by Region (2016-2021)
8.2.2 Asia Pacific Carboplatin API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Carboplatin API Market Size YoY Growth 2016-2027
9.2 Europe Carboplatin API Market Facts & Figures by Country
9.2.1 Europe Carboplatin API Sales by Country (2016-2021)
9.2.2 Europe Carboplatin API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Carboplatin API Market Size YoY Growth 2016-2027
10.2 Latin America Carboplatin API Market Facts & Figures by Country
10.2.1 Latin America Carboplatin API Sales by Country (2016-2021)
10.2.2 Latin America Carboplatin API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Carboplatin API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Carboplatin API Market Facts & Figures by Country
11.2.1 Middle East and Africa Carboplatin API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Carboplatin API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Umicore
12.1.1 Umicore Corporation Information
12.1.2 Umicore Description and Business Overview
12.1.3 Umicore Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Umicore Carboplatin API Products Offered
12.1.5 Umicore Recent Development
12.2 Tapi Teva
12.2.1 Tapi Teva Corporation Information
12.2.2 Tapi Teva Description and Business Overview
12.2.3 Tapi Teva Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Tapi Teva Carboplatin API Products Offered
12.2.5 Tapi Teva Recent Development
12.3 Vinkem Labs
12.3.1 Vinkem Labs Corporation Information
12.3.2 Vinkem Labs Description and Business Overview
12.3.3 Vinkem Labs Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Vinkem Labs Carboplatin API Products Offered
12.3.5 Vinkem Labs Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Description and Business Overview
12.4.3 Cipla Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cipla Carboplatin API Products Offered
12.4.5 Cipla Recent Development
12.5 Chem Genix
12.5.1 Chem Genix Corporation Information
12.5.2 Chem Genix Description and Business Overview
12.5.3 Chem Genix Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chem Genix Carboplatin API Products Offered
12.5.5 Chem Genix Recent Development
12.6 Fresenius Kabi Oncology
12.6.1 Fresenius Kabi Oncology Corporation Information
12.6.2 Fresenius Kabi Oncology Description and Business Overview
12.6.3 Fresenius Kabi Oncology Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Oncology Carboplatin API Products Offered
12.6.5 Fresenius Kabi Oncology Recent Development
12.7 Heraeus
12.7.1 Heraeus Corporation Information
12.7.2 Heraeus Description and Business Overview
12.7.3 Heraeus Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Heraeus Carboplatin API Products Offered
12.7.5 Heraeus Recent Development
12.8 Johson Matthey
12.8.1 Johson Matthey Corporation Information
12.8.2 Johson Matthey Description and Business Overview
12.8.3 Johson Matthey Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johson Matthey Carboplatin API Products Offered
12.8.5 Johson Matthey Recent Development
12.9 Qilu Pharmaceutial
12.9.1 Qilu Pharmaceutial Corporation Information
12.9.2 Qilu Pharmaceutial Description and Business Overview
12.9.3 Qilu Pharmaceutial Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Qilu Pharmaceutial Carboplatin API Products Offered
12.9.5 Qilu Pharmaceutial Recent Development
12.10 Hangzhou Longshine Bio-Tech
12.10.1 Hangzhou Longshine Bio-Tech Corporation Information
12.10.2 Hangzhou Longshine Bio-Tech Description and Business Overview
12.10.3 Hangzhou Longshine Bio-Tech Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hangzhou Longshine Bio-Tech Carboplatin API Products Offered
12.10.5 Hangzhou Longshine Bio-Tech Recent Development
12.11 Umicore
12.11.1 Umicore Corporation Information
12.11.2 Umicore Description and Business Overview
12.11.3 Umicore Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Umicore Carboplatin API Products Offered
12.11.5 Umicore Recent Development
12.12 Kunming Guiyan Pharmaceutical
12.12.1 Kunming Guiyan Pharmaceutical Corporation Information
12.12.2 Kunming Guiyan Pharmaceutical Description and Business Overview
12.12.3 Kunming Guiyan Pharmaceutical Carboplatin API Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kunming Guiyan Pharmaceutical Products Offered
12.12.5 Kunming Guiyan Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Carboplatin API Industry Trends
13.2 Carboplatin API Market Drivers
13.3 Carboplatin API Market Challenges
13.4 Carboplatin API Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Carboplatin API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(アプリケーションソフト)の最新刊レポート

本レポートと同じKEY WORD(api)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る